5AM Opportunities I (GP), LLC
10% owner at ELVN; 10% owner at Pear Therapeutics, Inc.; 10% owner at scPharmaceuticals Inc., and 1 more
- Sold, on record
- $19M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jan 31, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 4
- Filed as an executive or holder
Companies
- ELVNEnliven Therapeutics, Inc.10% owner
- Pear Therapeutics, Inc.10% owner
- scPharmaceuticals Inc.10% owner
- APREAprea Therapeutics, Inc.Other
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Pear Therapeutics, Inc.558,168 shares
- ELVN500,000 shares
- APRE315,000 shares
- scPharmaceuticals Inc.270,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale APREUnusualJun 16 2020
Sold 140,000 shares at $33.30 ($4.7M)
5AM Opportunities I (GP), LLC, 10% owner
Sold 30.9% of holdings ($15.1M position)313,497 shares leftFirst sale on recordFiling
- 2 Form 4 sale APREUnusualOct 5 +111 days
Sold 175,000 shares at $25.30 ($4.4M)
5AM Opportunities I (GP), LLC, Other
Sold 55.8% of holdings ($7.9M position)138,497 shares leftFiling
- 3 Form 4 sale scPharmaceuticals Inc.UnusualApr 11 +553 days
Sold 270,000 shares at $5.00 ($1.4M)
5AM Opportunities I (GP), LLC, 10% owner
Sold 33.4% of holdings ($4M position)537,301 shares leftFirst sale on recordFiling
- 4 Form 4 sale Pear Therapeutics, Inc.UnusualSep 16 +158 days
Sold 558,168 shares at $1.88 ($1M)
5AM Opportunities I (GP), LLC, 10% owner
Sold 50.8% of holdings ($2.1M position)541,235 shares leftFirst sale on recordFiling
- 5 Form 4 sale ELVNUnusualJan 31 +502 days
Sold 500,000 shares at $15.00 ($7.5M)
5AM Opportunities I (GP), LLC, 10% owner
No 10b5-1 planSold 39.3% of holdings ($19.1M position)771,983 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 | ELVN | 10% owner | Form 4 sale | 500,000 | $7.5M | 39.3% | Unusual | SEC |
| Sep 16, 2022 | Pear Therapeutics, Inc. | 10% owner | Form 4 sale | 558,168 | $1M | 50.8% | Unusual | SEC |
| Apr 11, 2022 | scPharmaceuticals Inc. | 10% owner | Form 4 sale | 270,000 | $1.4M | 33.4% | Unusual | SEC |
| Oct 5, 2020 | APRE | Other | Form 4 sale | 175,000 | $4.4M | 55.8% | Unusual | SEC |
| Jun 16, 2020 | APRE | 10% owner | Form 4 sale | 140,000 | $4.7M | 30.9% | Unusual | SEC |